4//SEC Filing
Klee Justin B. 4
Accession 0000950170-25-015701
CIK 0001658551other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 8:17 PM ET
Size
6.6 KB
Accession
0000950170-25-015701
Insider Transaction Report
Form 4
Klee Justin B.
DirectorCo-Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-05$1.57/sh+36,310$57,007→ 3,201,243 total - Exercise/Conversion
Stock Option (right to buy)
2025-02-05−36,310→ 0 totalExercise: $1.57Exp: 2025-02-26→ Common Stock (36,310 underlying)
Footnotes (1)
- [F1]This option is fully vested and exercisable.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001898314
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 8:17 PM ET
- Size
- 6.6 KB